InvestorsHub Logo
icon url

hardlesson

08/27/21 9:14 AM

#84953 RE: hardlesson #84949

'The increase in Cash is primarily attributable to $55,000,
of revenue received in cash pursuant to a license granted by the Company to Oncology Pharma, Inc. and $300,000 received by the Company from the sale of investment securities offset by expenses paid in the operation of the Company’s business, a loan made to an entity under common control, and the paying down of $47,900 of principal indebtedness owed by the Company to an entity under common control.'
icon url

Skiluc

08/27/21 9:15 AM

#84955 RE: hardlesson #84949

Hello? Anybody Home? Great post!
icon url

qualityincolor

08/27/21 9:19 AM

#84963 RE: hardlesson #84949

This folks!! Great post!!
icon url

Jrossco

08/27/21 9:20 AM

#84965 RE: hardlesson #84949

Great post. Thanks for sharing this.